Why the study?
Do elevated preoperative neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) predict mortality in patients undergoing major vascular surgery?
Do elevated preoperative neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) predict mortality in patients undergoing major vascular surgery?
Elevated preoperative neutrophil-lymphocyte ratio (≥5) and platelet-lymphocyte ratio (≥200) are associated with increased postoperative mortality risk in patients undergoing major vascular surgery.
Answers are grounded in this paper and cite their sources.
May aid preoperative risk stratification in vascular surgery; hypothesis-generating and requires prospective validation before clinical adoption.
Background: This study aims to examine whether preoperative neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) had a preoperative prognostic role and its association with survival in patients undergoing major vascular surgery. Methods: Between June 2005 and December 2012, 838 consecutive patients (593 males, 245 females; mean age 63 years; range, 10 to 99 years) who underwent major vascular surgery in our clinic were included. The NLR and PLR were determined by dividing the absolute neutrophil and platelet count by the absolute lymphocyte count. Results: The mean mortality risk was 2.85 (range 1.67- 4.87) in patients with a NLR of ≥5 and 3.76 (range 2.31- 6.12) in patients with a PLR of ≥200. The proportion of diabetic patients was significantly higher for patients with NLR ≥ 5 ( 63.7%; p = 0 .000) a nd P LR ≥ 200 ( %53.8; p = 0.003). Conclusion: Our study results showed that increased levels of NLR and PLR were directly correlated with mortality and inversely correlated with survival in the postoperative period and that diabetic patients were under a higher risk.
No takes yet. Share an insight, caveat, or question.
Mustafa Kemal Demirağ (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: